GUNZE (3002) FY2027 Q1 Earnings Report

Quick View

Executive Summary

For Q1 of the fiscal year ending March 2027, Gunze posted a substantial profit increase despite a decline in revenue, with a marked improvement in profitability representing the key takeaway. Against revenue of ¥3.137B (前年比-2.7%), Operating Income was ¥0.339B (same period +87.6%), Ordinary Income was ¥0.342B (same period +86.0%), and Net Income was ¥0.266B (a return to profitability from ¥-1.45B in the previous-year period). The Operating Income margin improved significantly to 10.8% from approximately 5.6% in the previous-year period, driven by growth in the core Functional Solutions Business and improved profitability in the Apparel Business.

Factors Affecting Results

【Revenue】Consolidated revenue was ¥3.137B, down 2.7% year on year. While the Functional Solutions Business (¥1.235B, same period +7.3%) and Life Create Business (¥0.306B, same period +1.3%) secured revenue growth, the Apparel Business (¥1.332B, same period -9.8%) and Medical Business (¥0.292B, same period -7.0%) recorded declines, resulting in an overall downward revenue trend.

【Profit and Loss】Operating Income was ¥0.339B, up 87.6% year on year. The gross margin improved to 36.7% (approximately 32.9% in the previous-year period), while SG&A expenses declined 8.6% to ¥0.813B. By segment, profit from the Apparel Business improved sharply to ¥0.118B (same period +226.4%, profit margin 8.9%), while the Functional Solutions Business also posted ¥0.253B (same period +59.7%, profit margin 20.4%), serving as the core contributor to company-wide profit. The Medical Business was the only segment to record a profit decline, with profit of ¥0.031B (same period -41.7%). Nonordinary gains and losses consisted of gains of ¥0.007B and losses of ¥0.009B, respectively, and were minor on a net basis; the primary reason for the gap between Ordinary Income and Net Income was the deduction of ¥0.074B in income taxes and other taxes. In conclusion, the company recorded lower revenue but higher profit.

Segment Analysis

The Functional Solutions Business accounted for the core of consolidated profit, with segment profit of ¥0.253B (profit margin 20.4%), achieving both revenue and profit growth. Although revenue in the Apparel Business declined 9.8%, segment profit improved substantially by 226.4%, and the profit margin rose from the low level of the previous-year period to nearly 9%. The Life Create Business recorded moderate revenue and profit growth, with revenue of ¥0.306B (same period +1.3%) and profit of ¥0.032B (same period +30.5%). The Medical Business was the only segment to record both lower revenue and lower profit, with revenue of ¥0.292B (same period -7.0%) and profit of ¥0.031B (same period -41.7%), making it an area requiring rebalancing within the company.

Key Financial Indicators

【Profitability】The Operating Income margin of 10.8% and Net Income margin of 8.5% both improved substantially from the previous-year period (Operating Income margin approximately 5.6%, Net Income margin approximately -4.5%). The gross margin was 36.7%.【Cash Quality】Cash and deposits were ¥1.092B, up 10% year on year, while trade receivables of ¥2.331B and inventories of ¥1.858B accounted for a considerable proportion of assets.【Investment Efficiency】ROE remained at 2.4%, with the low total asset turnover ratio offsetting the effect of improved profit margins. EPS was ¥84.23 (a return to profitability from ¥-45.37 in the previous-year period), and BPS was ¥3,440.20.【Financial Soundness】The Equity Ratio was 71.1%, while interest-bearing debt remained limited at ¥0.526B in long-term borrowings and ¥0.099B in short-term borrowings, indicating low and stable financial leverage.

Cash Flow Analysis

As detailed disclosure of the statement of cash flows is not included in these financial results, cash trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥1.092B, an increase of ¥0.099B from ¥0.994B in the previous-year period, providing substantial short-term financial capacity equivalent to 11 times short-term borrowings of ¥0.099B. Meanwhile, trade receivables of ¥2.331B and inventories of ¥1.858B both remained at high levels, suggesting that funds continued to be tied up in working capital despite the profit increase. Although accounts payable increased year on year to ¥0.755B, the pace of increase did not match that of trade receivables and inventories, indicating a structure in which the conversion of profit generated from operating activities into cash requires time. Property, plant and equipment stood at ¥6.798B and remained broadly flat, indicating that the company is not in a phase of major investment.

Quality of Earnings

The improvement in profit can be considered high quality because it was primarily supported by structural improvement at the operating level, with the net impact of nonordinary gains and losses limited to a loss of ¥0.002B. Nonoperating income was ¥0.038B, primarily consisting of dividend income of ¥0.010B, while nonoperating expenses were ¥0.034B, including interest expenses of ¥0.003B and other nonoperating expenses of ¥0.009B. The difference between Ordinary Income and Net Income was primarily attributable to income taxes and other taxes of ¥0.074B, and no items suggesting temporary accounting manipulation were identified. On the other hand, comprehensive income of ¥0.288B exceeded Net Income of ¥0.266B, primarily due to a positive contribution of ¥0.043B from foreign currency translation adjustments; attention should therefore be paid to the fact that a nonrecurring foreign exchange valuation factor boosted comprehensive income. The continued high levels of trade receivables and inventories represent accrual factors that create a certain gap between reported profit and actual cash flow, warranting close monitoring of the degree of earnings realization going forward.

Earnings Forecast and Guidance

The full-year company forecasts are revenue of ¥13.20B (前年比+0.8%), Operating Income of ¥0.880B (same period +80.3%), and Ordinary Income of ¥0.840B (same period +70.7%). As of Q1, progress rates were 23.8% for revenue, 38.5% for Operating Income, and 40.7% for Ordinary Income, significantly exceeding the standard profit progress benchmark of approximately 25%. However, the full-year forecasts themselves already incorporate Operating Income growth of more than 80% year on year, and it should be noted that the strong first-half progress may be accompanied by a subsequent reaction in the second half or changes in the business mix. Neither the earnings forecast nor the dividend forecast had been revised as of the current quarter.

Shareholder Returns

The full-year forecast dividend per share is ¥216, consisting of an ordinary dividend of ¥147 and a special dividend of ¥69. The Payout Ratio against forecast full-year EPS of ¥165.89 is approximately 130%, a level at which current-period profit alone is insufficient to fund the dividend. The company has retained earnings of ¥6.562B and cash and deposits of ¥1.092B, ensuring short-term payment capacity; however, the sustainability of the ¥69 special dividend will depend on future profit and cash-generation capacity. No disclosure regarding share repurchases was made, and this report evaluates shareholder returns based on the Payout Ratio.

Risk Factors

1. Risk of prolonged working capital cycles: Trade receivables of ¥2.331B and inventories of ¥1.858B remain at high levels, and prolonged collection and inventory turnover periods could constrain capital efficiency. In particular, profitability in the Apparel Business continues to improve despite lower revenue, making trends in inventory valuation and discounting important.

2. Variation among business segments: The Medical Business was the only business to record lower profit, with revenue down 6.8% and segment profit down 41.7%, increasing the company’s dependence on profit from the Functional Solutions Business and Apparel Business.

3. Sustainability of the high Payout Ratio: The full-year forecast Payout Ratio is approximately 130%, and maintaining the level of shareholder returns including the ¥69 special dividend will depend on future profit growth and cash-generation capacity.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability exceeds the industry median and is positioned in the upper range of the IQR.

Growth and Capital Efficiency

The revenue growth rate is substantially below the industry median and is near the lower bound of the IQR.

Source: Compiled by the Company

Key Takeaways from the Financial Results

1. While revenue declined 2.7% year on year, Operating Income increased 87.6%, representing a substantial improvement in profitability. The primary drivers were higher margins in the Functional Solutions Business and improved profitability in the Apparel Business, with changes in the business mix supporting the profit structure.

2. Full-year progress rates for Operating Income and Ordinary Income were 38.5% and 40.7%, respectively, exceeding standard progress levels, while the revenue progress rate remained at 23.8%. Whether revenue recovers in the second half will be key to achieving the full-year plan.

3. Trade receivables and inventories continue to remain at high levels, making the speed of cash conversion of profit during the profit-growth phase an important financial metric going forward.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,963–¥3,124 at ±1% for the cost of equity, and ¥3,030–¥3,049 at ±0.1 for ω.

Notes:

• As progress of Net Income against the full-year forecast (51%) exceeds the standard level (25%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of forecast tend to exceed their forecasts. In businesses with strong seasonality, the adjustment may be excessive).
• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Gunze delivered a strong FY2027 Q1 profit recovery despite a 2.7% year-on-year decline in revenue to ¥31.37bn. Operating income rose 87.6% to ¥3.39bn, lifting the operating margin to 10.8% from 5.6% a year earlier. Gross profit increased 8.6% to ¥11.52bn even as sales declined. The gross margin expanded by approximately 380bp to 36.7%, indicating a substantially improved product mix, pricing and/or manufacturing cost outcome. SG&A expense declined 7.6% to ¥8.13bn, and the SG&A-to-sales ratio improved by approximately 140bp to 25.9%. This combination of gross-margin expansion and lower fixed costs generated approximately 520bp of operating-margin expansion. Ordinary income increased 86.0% to ¥3.42bn. Profit attributable to owners of parent was ¥2.64bn, compared with a ¥1.47bn loss in the previous-year quarter. The net profit margin accordingly improved to 8.4% from negative 4.6%. The prior-year result included ¥3.43bn of restructuring costs within extraordinary losses, so the year-on-year net-income swing materially reflects the absence of that exceptional charge as well as the underlying operating recovery. Current-quarter extraordinary income of ¥0.74bn and extraordinary loss of ¥0.95bn produced only a modest net ¥0.21bn pre-tax drag. Functional Solutions was the principal earnings contributor, while Apparel delivered the largest incremental segment-profit improvement. Medical remained profitable but experienced both sales and margin pressure. Q1 operating-income progress reached 38.5% of the ¥8.80bn full-year forecast, well above the standard 25% quarterly run rate. Profit attributable to owners reached 50.8% of the ¥5.20bn forecast, also materially ahead of the standard pace. Revenue progress was 23.8% of the full-year target, slightly below a straight-line 25%, meaning management's full-year outlook requires margin resilience rather than a meaningful acceleration in sales. The balance sheet remains conservatively capitalized, but the long working-capital cycle and forecast dividend payout above 100% of projected EPS are central items to monitor.

Profitability Analysis

Annualized DuPont ROE is 9.6%, comprising an 8.4% net profit margin, 0.812x asset turnover and 1.41x financial leverage. The dominant driver of the recovery is margin rather than balance-sheet leverage: financial leverage is modest, while operating margin expanded to 10.8% from 5.6% and gross margin rose to 36.7% from 32.9%. Annualized asset turnover of 0.812x is moderate for a manufacturing group with PPE representing 44.0% of assets and sizeable inventories. The 8.4% net margin is within the 5-10% good range, although the 9.6% annualized ROE remains just below the 10% threshold generally associated with a good return profile. Functional Solutions is the core business by segment profit, contributing ¥2.53bn of ¥4.35bn aggregate segment profit; revenue grew 7.5% to ¥12.20bn and segment profit rose 59.7%, with margin improving to 20.7% from 13.9%. Apparel revenue declined 10.5% to ¥13.19bn, but segment profit increased 226.4% to ¥1.19bn and margin rose to 9.0% from 2.5%, making it the largest source of incremental segment earnings. Medical revenue fell 7.0% to ¥2.93bn and segment profit fell 41.7% to ¥0.32bn, compressing its margin to 10.8% from 17.2%. Life Create revenue increased 1.4% to ¥3.05bn and segment profit increased 30.5% to ¥0.32bn, with margin expanding to 10.5% from 8.2%. Unallocated corporate costs increased to ¥0.96bn from ¥0.93bn, but this was more than offset by the ¥1.62bn increase in aggregate segment profit. Interest coverage of 105.84x and an interest burden of 1.004 indicate that financing costs are immaterial to current profitability.

Growth Assessment

The sales decline shows that the Q1 recovery is profit-led rather than volume-led. Functional Solutions' 7.5% sales growth provides the clearest evidence of a growth engine, while Life Create added modest growth. Conversely, the 10.5% decline in Apparel sales and 7.0% decline in Medical sales make the revenue base uneven. Apparel's sharp margin recovery is encouraging, but its sustainability depends on maintaining improved profitability while restoring demand. The full-year forecast assumes only 0.8% revenue growth to ¥132.00bn, consistent with management not relying on a broad-based top-line rebound. In contrast, the forecast calls for operating income growth of 80.3% to ¥8.80bn, placing execution emphasis on the durability of Q1 gross-margin gains and cost discipline. Q1 operating-income progress of 38.5% is 13.5 percentage points above the 25% standard quarterly pace. Q1 net-income progress of 50.8% is 25.8 percentage points above the standard pace. The outperformance creates room against the stated forecast, but the appropriate interpretation depends on whether the Functional Solutions and Apparel margin gains persist through later quarters. Non-operating income was ¥0.38bn, or only 1.2% of revenue, so reported profit is principally supported by operating earnings rather than non-operating income.

Financial Health

Liquidity is strong, with a current ratio of 218.1%, a quick ratio of 161.0%, and working capital of ¥38.40bn. Current assets of ¥70.91bn substantially exceed current liabilities of ¥32.51bn, limiting near-term refinancing and maturity-mismatch risk. Cash and deposits of ¥10.93bn cover short-term loans of ¥0.99bn by 11.06x. Interest-bearing debt totals ¥6.25bn, equivalent to a conservative 0.41x debt-to-equity ratio and 5.4% debt-to-capital ratio. Long-term loans of ¥5.26bn constitute the majority of loans, while short-term loans are limited. Commercial paper increased to ¥7.50bn from ¥2.00bn year on year, a 275% increase, and should be monitored as a change in short-term funding mix despite the ample current-ratio cushion. Total liabilities represent 28.9% of total assets and total equity represents 71.1%, reflecting a robust equity-funded capital structure. The capital adequacy ratio declined to 69.8% from 72.8%, principally alongside higher liabilities and lower equity, but remains high in absolute terms. Net defined benefit liability is ¥2.57bn, a manageable obligation relative to owners' equity of ¥107.84bn.

Notable B/S Changes

Commercial paper: +¥5.50bn (+275%) to ¥7.50bn - substantial increase in short-term market funding; liquidity remains strong but funding-mix trends warrant monitoring. Total equity: -¥3.89bn (-3.4%) to ¥109.86bn - reduced equity buffer and capital adequacy ratio, although capitalization remains robust. Accounts receivable: +¥0.75bn (+3.3%) to ¥23.31bn despite a 2.7% sales decline - consistent with the 68-day DSO alert and requiring attention to collections. Finished goods: -¥0.53bn (-2.8%) to ¥18.58bn - inventory reduction is constructive, but the balance remains associated with elevated inventory-day alerts.

Cash Flow Quality

The available balance-sheet indicators point to a working-capital-intensive earnings model. Accounts receivable rose 3.3% year on year to ¥23.31bn while revenue declined 2.7%, and the annualized DSO alert of 68 days exceeds the 60-day warning threshold. This raises the risk that cash collection is lagging reported sales, particularly if the receivable increase persists in subsequent quarters. Inventory totaled ¥18.58bn, equivalent to 12.0% of total assets. The quality alerts identify inventory days of 152 days under one measure and 85 days under another; both exceed their respective warning benchmarks of 90 days and 60 days. Using annualized Q1 cost of sales, the 85-day measure is consistent with the reported inventory balance and indicates slow inventory conversion for a manufacturer. Raw materials were ¥6.74bn and work in process was ¥7.73bn, with the latter exceeding raw materials, which warrants attention to production-cycle efficiency and potential bottlenecks. Finished goods were ¥18.58bn and declined 2.8% year on year, offering some evidence of inventory reduction, but the elevated inventory-day alerts remain material. The cash-conversion-cycle alert of 185 days is well above the 120-day warning threshold, signaling that significant capital is tied up between production, collection and supplier settlement. The separate annualized 85-day inventory metric implies a shorter cycle than the 185-day alert, but neither reading supports an efficient working-capital profile. These alerts matter because a prolonged cash conversion cycle can constrain internally generated funds even when accounting margins improve.

Dividend Sustainability

The full-year dividend forecast is ¥216 per share, comprising a ¥147 ordinary dividend and a ¥69 special dividend. Against forecast EPS of ¥165.89, the dividend-only payout ratio is approximately 130.2%, above the 100% warning threshold. The ordinary dividend alone represents an approximately 88.6% payout ratio versus forecast EPS, which is also elevated. Based on 31.35 million average shares, the forecast dividend implies approximately ¥6.77bn of aggregate distributions, compared with forecast profit attributable to owners of ¥5.20bn. The special dividend is therefore important to the above-100% payout outcome and makes the distribution less representative of recurring shareholder returns. The strong equity base, low debt burden and Q1 earnings progress provide balance-sheet capacity, but sustained dividends above earnings require either accumulated cash, asset monetization or a normalization of the special component. Dividend sustainability should therefore be assessed primarily against the durability of operating margins, inventory conversion and the eventual treatment of the special dividend.

Risk Assessment

Business risks include Demand and mix risk: Apparel sales declined 10.5% year on year and Medical sales declined 7.0%, leaving the group dependent on Functional Solutions growth and Apparel margin recovery., Manufacturing working-capital risk: DSO of 68 days exceeds the 60-day alert threshold, while inventory-day alerts of 152 days and 85 days both indicate slow conversion of inventory to cash., Inventory and production risk: Work in process of ¥7.73bn exceeds raw materials of ¥6.74bn, and the long cash conversion cycle alert of 185 days indicates potential production-flow, forecasting or stock-management inefficiency., Industry-specific input-cost and supply-chain risk: As a manufacturer with significant PPE and inventories, earnings remain exposed to raw-material, energy, logistics and component-cost volatility, particularly if demand conditions limit price pass-through., Margin sustainability risk: The Q1 earnings beat rests on gross-margin expansion of approximately 380bp and SG&A ratio improvement of approximately 140bp despite lower revenue; any reversal in pricing, mix or utilization could materially reduce profit..

Financial risks include Funding-mix risk: Commercial paper increased by ¥5.50bn, or 275% year on year, although liquidity ratios and cash coverage of short-term loans remain strong., Capital-return risk: The forecast dividend-only payout ratio of approximately 130% exceeds projected earnings and relies on financial capacity beyond annual profit generation., Equity-buffer trend: Total equity declined 3.4% year on year to ¥109.86bn and the capital adequacy ratio fell 3.0 percentage points to 69.8%, though both remain robust..

Key concerns include Highest priority: conversion of the profit recovery into cash through lower receivable days, inventory days and cash conversion cycle., High priority: whether Functional Solutions can sustain its 20.7% segment margin and whether Apparel can preserve its 9.0% margin while rebuilding sales., Moderate priority: the Q1 profit run rate is ahead of full-year guidance, but sales progress is below a straight-line quarterly pace; later-quarter revenue and margin trends will determine the durability of the beat., Moderate priority: the ¥69 special dividend component and above-100% forecast payout ratio heighten sensitivity of shareholder distributions to earnings and liquidity outcomes..

Investment Implications

Key takeaways include Operating profit nearly doubled to ¥3.39bn despite lower sales, driven by a 520bp operating-margin expansion., Functional Solutions is the earnings anchor, contributing ¥2.53bn of segment profit at a 20.7% margin., Apparel's profit turnaround is substantial, but it occurred alongside a 10.5% sales decline., Q1 operating-income and net-income progress materially exceed standard seasonal benchmarks relative to unchanged full-year guidance., The capital structure is conservative, with 0.41x debt-to-equity and a 218.1% current ratio., Working-capital efficiency and a forecast dividend payout ratio above 100% are the principal counterweights to the earnings recovery..

Metrics to watch include Functional Solutions revenue growth and segment margin, Apparel revenue trajectory and ability to sustain a 9.0% segment margin, Medical segment sales and margin recovery, Gross margin and SG&A-to-sales ratio, Annualized DSO, inventory days and cash conversion cycle, Commercial paper balance and short-term funding mix, Progress versus the ¥132.00bn revenue and ¥8.80bn operating-income full-year forecasts, Treatment and sustainability of the ¥69 per-share special dividend.

Regarding relative positioning, Gunze combines an improving 10.8% operating margin, high capital adequacy and very low balance-sheet leverage with a less favorable manufacturing working-capital profile. Its annualized 9.6% ROE is respectable but remains below the 10-15% range generally associated with stronger returns, and the recovery is more margin-driven than revenue-driven.